Literature DB >> 7271300

Use of DNA estimation for growth assessment in normal and hypoplastic fetal lungs.

J S Wigglesworth, R Desai.   

Abstract

Total DNA was estimated in the lungs of 80 fetuses and newborn infants varying in gestation from 14 weeks to term. In fetuses of appropriate weight for gestational age total lung DNA increased at a constant rate from about 35 mg at 17 weeks' gestation to 480 mg at term. The lungs of immature fetuses were heavier and contained more DNA relative to body weight than did those of mature infants. Small-for-dates infants had lower lung DNA levels for gestation than infants with weights appropriate for gestational age, but there was no difference when lung DNA was corrected for body weight. Lung hypoplasia defined in terms of lung/body weight ratio was associated with low lung DNA content for gestation, even when corrected for body weight. The total lung DNA at 34-40 weeks' gestation in infants with lung hypoplasia associated with fetal anuria or urinary outflow obstruction was equivalent to that seen in normal fetuses at 20-22 weeks' gestation. We conclude that the early second trimester is a critical period for human fetal lung growth.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271300      PMCID: PMC1627277          DOI: 10.1136/adc.56.8.601

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  NEWBORN AFTER PROLONGED LEAKAGE OF LIQUOR AMNII.

Authors:  A D BAIN; I I SMITH; I K GAULD
Journal:  Br Med J       Date:  1964-09-05

2.  BILATERAL ABSENCE OF URETERS AND KIDNEYS: A REPORT OF 50 CASES.

Authors:  E L POTTER
Journal:  Obstet Gynecol       Date:  1965-01       Impact factor: 7.661

3.  Volume of liquor amnii in normal and abnormal pregnancy.

Authors:  P M ELLIOTT; W H INMAN
Journal:  Lancet       Date:  1961-10-14       Impact factor: 79.321

4.  The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood.

Authors:  J L EMERY; A MITHAL
Journal:  Arch Dis Child       Date:  1960-12       Impact factor: 3.791

5.  Aetiology of hyaline membrane disease.

Authors:  J S Wigglesworth
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

6.  Effect on lung growth of cervical cord section in the rabbit fetus.

Authors:  J S Wigglesworth; R Desai
Journal:  Early Hum Dev       Date:  1979-03       Impact factor: 2.079

7.  Primary pulmonary hypoplasia in the neonate.

Authors:  L E Swischuk; C J Richardson; M M Nichols; M J Ingman
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

8.  The lungs in congenital bilateral renal agenesis and dysplasia.

Authors:  A Hislop; E Hey; L Reid
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

9.  Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis.

Authors:  S S Askenazi; M Perlman
Journal:  Arch Dis Child       Date:  1979-08       Impact factor: 3.791

10.  Fetal lung hypoplasia: biochemical and structural variations and their possible significance.

Authors:  J S Wigglesworth; R Desai; P Guerrini
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

View more
  11 in total

1.  Histometry and three-dimensional image reconstruction of the lung in congenital diaphragmatic hernia.

Authors:  T Kato; H Yoshino; K Matsuda; T Murakoshi; T Hebiguchi; K Koyama; M Saito; K Saito
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

2.  The Effects of Hemodynamic Alterations on Lung Volumes in Fetuses with Tetralogy of Fallot: An MRI Study.

Authors:  Vanessa Berger-Kulemann; Rudolf Berger; Elisabeth Mlczoch; Daniel Sternal; Mariella Mailath-Pokorny; Nilouparak Hachemian; Daniela Prayer; Michael Weber; Ulrike Salzer-Muhar
Journal:  Pediatr Cardiol       Date:  2015-04-18       Impact factor: 1.655

3.  Familial primary pulmonary hypoplasia.

Authors:  B C Hamel
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

4.  Early lung growth and chronic airflow obstruction.

Authors:  S Shaheen; D J Barker
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

5.  Pulmonary hypoplasia secondary to oligohydramnios with very premature rupture of fetal membranes.

Authors:  D Tibboel; J L Gaillard; R Spritzer; H C Wallenburg
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

6.  Fetal abnormality: an audit of its recognition and management. Northern Regional Survey Steering Group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

7.  Fetal lung hypoplasia: biochemical and structural variations and their possible significance.

Authors:  J S Wigglesworth; R Desai; P Guerrini
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

8.  Postmortem Findings for 7 Neonates with Congenital Zika Virus Infection.

Authors:  Anastácio Q Sousa; Diane I M Cavalcante; Luciano M Franco; Fernanda M C Araújo; Emília T Sousa; José Telmo Valença-Junior; Dionne B Rolim; Maria E L Melo; Pedro D T Sindeaux; Marialva T F Araújo; Richard D Pearson; Mary E Wilson; Margarida M L Pompeu
Journal:  Emerg Infect Dis       Date:  2017-07-15       Impact factor: 6.883

9.  Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).

Authors:  Augustinus S P van Teeffelen; David P van der Ham; Christine Willekes; Salwan Al Nasiry; Jan G Nijhuis; Sander van Kuijk; Ewoud Schuyt; Twan L M Mulder; Maureen T M Franssen; Dick Oepkes; Fenna A R Jansen; Mallory D Woiski; Mireille N Bekker; Caroline J Bax; Martina M Porath; Monique W M de Laat; Ben W Mol; Eva Pajkrt
Journal:  BMC Pregnancy Childbirth       Date:  2014-04-04       Impact factor: 3.007

10.  Pulmonary hypoplasia associated with congenital heart diseases: a fetal study.

Authors:  Isabelle Ruchonnet-Metrailler; Bettina Bessieres; Damien Bonnet; Shamila Vibhushan; Christophe Delacourt
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.